[1] Bang OY, Chung JW, Kim DH, Won HH, Yeon JY, Ki CS, Shin HJ, Kim JS, Hong SC, Kim DK, Koizumi A.Moyamoya disease and spectrums of RNF213 vasculopathy[J].Transl Stroke Res, 2020, 11:580-589. [2] WANG BL, SUN Y, LI Q, TONG XG.Clinical analysis of superficial temporal artery-middle cerebral artery bypass combined with temporoparietal fascia in the treatment of moyamoya disease[J].Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2022, 22:368-373.[王本琳, 孙杨, 李琪, 佟小光.颞浅动脉-大脑中动脉搭桥术联合带蒂颞顶筋膜瓣贴敷术治疗烟雾病疗效分析[J].中国现代神经疾病杂志, 2022, 22:368-373.] [3] Fang YC, Wei LF, Hu CJ, Tu YK.Pathological circulating factors in moyamoya disease[J].Int J Mol Sci, 2021, 22:1696. [4] Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, Ji X, Meng R.Progress in moyamoya disease[J].Neurosurg Rev, 2020, 43:371-382. [5] Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF.Epidemiology of moyamoya disease in Taiwan:a nationwide population-based study[J].Stroke, 2014, 45:1258-1263. [6] Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T.Prevalence and clinicoepidemiological features of moyamoya disease in Japan:findings from a nationwide epidemiological survey[J].Stroke, 2008, 39:42-47. [7] Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC.Pediatric moyamoya disease:an analysis of 410 consecutive cases[J].Ann Neurol, 2010, 68:92-101. [8] Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, Bang JS, Sohn CH, Paeng JC, Oh CW.Long-term outcomes after combined revascularization surgery in adult moyamoya disease[J].Stroke, 2014, 45:3025-3031. [9] Kim T, Oh CW, Bang JS, Kim JE, Cho WS.Moyamoya disease:treatment and outcomes[J].J Stroke, 2016, 18:21-30. [10] Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, Cho WS, Bang JS.Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia[J].J Neurosurg, 2016, 124:1788-1793. [11] Chinese Expert Consensus Writing Group on Treatment Moyamoya Disease.Chinese expert consensus on the diagnosis and treatment of moyamoya disease[J].Guo Ji Nao Xue Guan Bing Za Zhi, 2019, 27:645-650.[烟雾病治疗中国专家共识编写组.烟雾病治疗中国专家共识[J].国际脑血管病杂志, 2019, 27:645-650.] [12] Qiu YY, Chen JC, Zhang JJ, Yu J, Xu SX, Zhang JB, Wang SB.Relationship between postoperative intracranial hemorrhage and cerebral hyperperfusion syndrome after combined bypass in adult patients with moyamoya disease[J].Zhongguo Lin Chuang Shen Jing Wai Ke Za Zhi, 2019, 24:387-389.[邱永逸, 陈劲草, 章剑剑, 余金, 许双祥, 张继波, 王声播.成人烟雾病STA-MCA分流术联合EMS后脑出血和高灌注综合征的关[J].中国临床神经外科杂志, 2019, 24:387-389.] [13] Ding W, Chen XB, Huang QC, Wang MY, Huang CG, Duan FL.Clinical effect of anastomosis of superficial temporal artery to middle cerebral artery combined with temporal muscle sticking in the treatment of ischemic moyamoya disease in adults[J].Lin Chuang Wu Zhen Wu Zhi, 2019, 32:85-91.[丁伟, 陈晓斌, 黄乔春, 王孟阳, 黄从刚, 段发亮.颞浅动脉大脑中动脉血管吻合术联合颞肌贴敷术治疗成人缺血性烟雾病效果分析[J].临床误诊误治, 2019, 32:85-91.] [14] Cao L, He BZ, You HJ, Shi ZY, Zhang D, Dong Y, Yang B, Li WH.Comparative analysis of superficial temporal artery to middle cerebral artery bypass combined encephalo-myo-synangiosis or encephalo-duro-arterio-synangiosis in the treatment of moyamoya disease[J].Zhonghua Shen Jing Wai Ke Za Zhi, 2022, 38:171-176.[曹磊, 何秉征, 尤浩君, 石志勇, 张东, 董阳, 杨波, 李红伟.颞浅动脉-大脑中动脉搭桥术联合颞肌贴敷或颞浅动脉贴敷治疗烟雾病的疗效对比分析[J].中华神经外科杂志, 2022, 38:171-176.] [15] Yao QD, Zhang FS, Zhang GS, Yin HY, Zhang YP, Meng YJ.Short-term efficacy of superficial temporal artery-middle cerebral artery bypass combined with encephalo-myo-synangiosis in the treatment of adult moyamoya disease[J].Lin Chuang Yi Xue, 2020, 40:45-46.[姚庆东, 张福生, 张国顺, 殷会咏, 张一平, 孟艳举.颞浅动脉-大脑中动脉搭桥联合颞肌贴敷术治疗成人烟雾病的近期疗效[J].临床医学, 2020, 40:45-46.] [16] Zhu QM, Wu W.Research progress in cerebral hyperperfusion syndrome after moyamoya bypass surgery[J].Ju Jie Shou Shu Xue Za Zhi, 2021, 30:345-350.[朱乾渺, 吴伟.烟雾病血管搭桥术后高灌注综合征的研究进展[J].局解手术学杂志, 2021, 30:345-350.] [17] Kim SJ, Son TO, Kim KH, Jeon P, Hyun SH, Lee KH, Yeon JY, Kim JS, Hong SC, Shin HJ, Bang OY.Neovascularization precedes occlusion in moyamoya disease:angiographic findings in 172 pediatric patients[J].Eur Neurol, 2014, 72:299-305. [18] Kazumata K, Tha KK, Tokairin K, Ito M, Uchino H, Kawabori M, Sugiyama T.Brain structure, connectivity, and cognitive changes following revascularization surgery in adult moyamoya disease[J].Neurosurgery, 2019, 85:E943-952. [19] Yin H, Liu X, Zhang D, Zhang Y, Wang R, Zhao M, Zhao J.A novel staging system to evaluate cerebral hypoperfusion in patients with moyamoya disease[J].Stroke, 2018, 49:2837-2843. [20] Fan AP, Khalighi MM, Guo J, Ishii Y, Rosenberg J, Wardak M, Park JH, Shen B, Holley D, Gandhi H, Haywood T, Singh P, Steinberg GK, Chin FT, Zaharchuk G.Identifying hypoperfusion in moyamoya disease with arterial spin labeling and an[15O]-water positron emission tomography/magnetic resonance imaging normative database[J].Stroke, 2019, 50:373-380. [21] Liu Z, He S, Xu Z, Duan R, Yuan L, Xiao C, Yi Z, Wang R.Association between white matter impairment and cognitive dysfunction in patients with ischemic moyamoya disease[J].BMC Neurol, 2020, 20:302. [22] Su JB, Xi SD, Zhou SY, Zhang X, Jiang SH, Xu B, Chen L, Lei Y, Gao C, Gu YX.Microstructural damage pattern of vascular cognitive impairment:a comparison between moyamoya disease and cerebrovascular atherosclerotic disease[J].Neural Regen Res, 2019, 14:858-867. [23] Di F, Fan ZH, Li JJ.Influence of cognitive function in surgical and drug treatment for adult patients with moyamoya disease[J].Zhongguo Zu Zhong Za Zhi, 2015, 10:761-765.[邸飞, 范震红, 李俊杰.手术与药物治疗对成年烟雾病患者认知功能的影响[J].中国卒中杂志, 2015, 10:761-765.] [24] Acker G, Fekonja L, Vajkoczy P.Surgical management of moyamoya disease[J].Stroke, 2018, 49:476-482. [25] Li YX, Zhou SJ, Gao X, Chen XS, Zhang JJ.Application of superficial temporal artery-middle cerebral artery bypass combined with encephalo-myo-synangiosis in the treatment of adult moyamoya disease[J].Xian Dai Shi Yong Yi Xue, 2019, 31:325-327.[励宇翔, 周圣军, 高翔, 陈霄圣, 张均钧.颞浅动脉-大脑中动脉搭桥联合颞肌贴敷术在成人烟雾病治疗中的应用[J].现代实用医学, 2019, 31:325-327.] [26] Lei Y.A preliminary study on cognitive impairment in adults with moyamoya disease[D].Shanghai:Fudan University, 2014.[雷宇.成人烟雾病认知损害的初步研究[D].上海:复旦大学, 2014.] |